Visalytics
Visalytics
approved EB-2 (NIW)

Clinical Research Scientist

Biotechnologies · 2025-09-18

Processing Time
602 days
Decision Date
2025-09-18
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop innovative clinical trial methodologies to evaluate new treatments, vaccines, and medical devices. This work focuses on optimizing health outcomes and improving patient diagnosis through efficient testing of emerging medical technologies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research advances biotechnology innovation and public health by reducing the time and cost of drug development.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic record, publication history, and funding from GSK demonstrate they are well-positioned to continue their work.

3 Balance of Interests/Waiver Benefit Met

The petitioner's work in vaccine research and clinical methodologies provides a clear benefit to U.S. healthcare delivery and disease reduction.

Why This Petition Was Approved

The petition was approved based on 8 peer-reviewed journal articles and 295 citations that demonstrate global recognition. Additional evidence included 2 completed peer reviews for scientific journals, major funding from GlaxoSmithKline (GSK), and 4 expert recommendation letters satisfying the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions

Similar Cases

General Manager

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 27 days 2023-02-14
The petitioner proposes to continue research using biotechnological principles to analyze the interaction of viruses and drug therapies to improve public health. The work specifically focuses on developing novel methods to address major global diseases and remediate health concerns such as HIV and the Zika virus.
View Case

Postdoctoral Researcher

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
Tennessee 64 days 2025-03-13
The petitioner proposes to advance innovative immunization strategies and translational studies aimed at developing effective vaccines and therapeutics targeting infectious pathogens. The work focuses on investigating host-pathogen interactions and the underlying mechanisms of protective immune responses to strengthen public health systems.
View Case

Research Assistant

Research and Development · China

WeGreened EB-2 (NIW) approved
Florida 49 days 2024-10-31
The petitioner proposes to continue her research on developing innovative statistical methodologies that enhance the precision, efficiency, and reliability of clinical trials. Her work focuses on improving therapeutic outcomes, reducing costs and time for bringing treatments to market, and increasing the accessibility of life-saving treatments to reduce the U.S. disease burden.
View Case

Others

Pharmaceuticals · Iran

WeGreened EB-2 (NIW) approved
598 days 2025-09-08
The petitioner proposes to advance drug discovery by designing and improving in-vitro testing methodologies to enhance precision and streamline timelines in pre-clinical research. Her work focuses on creating standardized approaches for toxin assessment to reduce the reliance on animal testing and lower the high failure rates of clinical trials.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-18.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 602 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist